RedInk- Licensing Opportunity from Cork Institute of Technology- August 2015 front page preview

RedInk- Licensing Opportunity from Cork Institute of Technology- August 2015

RedInk is a SaaS based grading and assessment tool that differentiates itself on its rubric-based & has multimedia capabilities. The key modules of RedInk include: · Rubrics & Comment Manager: Create, search, share and e...

pdf 398.3KB

Novel Dual DNA Binding Molecule as a Treatment for Cancer - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015 front page preview

Novel Dual DNA Binding Molecule as a Treatment for Cancer - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015

A new class of multi-functional metallodrug candidates (M-HDAC inhibitor conjugates) has been developed with dual DNA binding, HDAC inhibitory activity, comparable cytotoxicity to classical Pt drugs and enhanced selectiv...

pdf 386.8KB

Treating diarrhoeal diseases with FXR agonists - Licensing Opportunity from Royal College of Surgeons in Ireland - July 2015 front page preview

Treating diarrhoeal diseases with FXR agonists - Licensing Opportunity from Royal College of Surgeons in Ireland - July 2015

The Farnesoid X receptor (FXR) is an important regulator of many physiological processes. There is currently a great deal of interest in therapeutically targeting FXR for a number of conditions, including liver disease, ...

pdf 219.8KB

Single step encapsulation technology for drug formulation - Licensing Opportunity from Royal College of Surgeons in Ireland - July 2015 front page preview

Single step encapsulation technology for drug formulation - Licensing Opportunity from Royal College of Surgeons in Ireland - July 2015

RCSI Researchers have developed a single step micro-encapsulation process (MicroPET) for use in drug formulation to enable the delayed release, sustained release or targeted delivery of active pharmaceutical ingredients....

pdf 238.4KB

Ground Breaking Discovery into the Causes of Amyotrophic Lateral Sclerosis (ALS) - Licensing Opportunity from Royal College of Surgeons in Ireland - July 2015 front page preview

Ground Breaking Discovery into the Causes of Amyotrophic Lateral Sclerosis (ALS) - Licensing Opportunity from Royal College of Surgeons in Ireland - July 2015

Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disorder of young and middle aged adults that is incurable and invariably fatal. Novel disease‐ specific mutations in a particular gene have recen...

pdf 318.3KB